Amgen (AMGN) EPS: History & Chart

Amgen Inc. (AMGN)AMGNAmgen Inc.

About Amgen Inc.

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma. Furthermore, Repatha plays a vital role in lowering the incidence of major cardiovascular events such as myocardial infarction, stroke, and coronary revascularization. Amgen's comprehensive product lineup also encompasses Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. The company distributes its therapies worldwide, primarily serving healthcare providers, including physicians and their clinics, dialysis centers, hospitals, and pharmacies. Distribution is facilitated through pharmaceutical wholesale distributors, complemented by direct-to-consumer channels. Amgen actively engages in strategic collaborations. It has partnered with entities such as Novartis Pharma AG, UCB, Bayer HealthCare LLC, BeiGene, Ltd., Eli Lilly and Company, Datos Health, and Verastem, Inc., to jointly assess VS-6766 when combined with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. Another key alliance involves Kyowa Kirin Co., Ltd., for the co-development and commercialization of KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody targeting atopic dermatitis and other autoimmune conditions. Additionally, Amgen maintains research and development partnerships with Neumora Therapeutics, Inc. and Plexium, Inc.

Thousand Oaks, CA

31,500 employees

www.amgen.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Robert A. Bradway

View full financials

AMGN Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

14.37

EARNINGS PER SHARE (EPS) AVG TTM

10.97

EARNINGS PER SHARE (EPS) AVG 3Y

11.67

EARNINGS PER SHARE (EPS) AVG 5Y

11.57

EARNINGS PER SHARE (EPS) AVG 10Y

10.66

EARNINGS PER SHARE (EPS) AVG 15Y

9.08

EARNINGS PER SHARE (EPS) AVG 20Y

7.71

CURRENT VS TTM AVG

+30.93%

CURRENT VS 3Y AVG

+23.11%

CURRENT VS 5Y AVG

+24.18%

CURRENT VS 10Y AVG

+34.79%

CURRENT VS 15Y AVG

+58.22%

CURRENT VS 20Y AVG

+86.34%

NAME	MARKET CAP	EARNINGS PER SHARE (EPS)	TTM	3Y	5Y
Amgen Inc. (AMGN)	$207.87B	14.37	10.97	11.67	11.57
Novo Nordisk A/S (NVO)vs ›	$209.19B	4.27	3.38	2.82	2.39
Thermo Fisher Scientific Inc. (TMO)vs ›	$213.42B	18.59	17.17	16.90	17.22
Abbott Laboratories (ABT)vs ›	$184.11B	3.11	5.71	4.66	4.19
Gilead Sciences, Inc. (GILD)vs ›	$161.66B	7.34	3.61	3.85	3.41
Pfizer Inc. (PFE)vs ›	$142.54B	1.31	1.39	2.19	2.39
Danaher Corporation (DHR)vs ›	$137.13B	5.63	5.20	6.66	6.73
Bristol-Myers Squibb Company (BMY)vs ›	$133.37B	4.54	-0.48	1.47	0.84
CVS Health Corp. (CVS)vs ›	$133.25B	2.27	2.53	3.71	4.39
AstraZeneca PLC (AZN)vs ›	$131.47B	13.28	11.14	8.54	6.53

NAME

MARKET CAP

EARNINGS PER SHARE (EPS)

TTM

Amgen Inc. (AMGN)

$207.87B

14.37

10.97

11.67

11.57

Novo Nordisk A/S (NVO)vs ›

$209.19B

4.27

3.38

2.82

2.39

Thermo Fisher Scientific Inc. (TMO)vs ›

$213.42B

18.59

17.17

16.90

17.22

Abbott Laboratories (ABT)vs ›

$184.11B

3.11

5.71

4.66

4.19

Gilead Sciences, Inc. (GILD)vs ›

$161.66B

7.34

3.61

3.85

3.41

Pfizer Inc. (PFE)vs ›

$142.54B

1.31

1.39

2.19

2.39

Danaher Corporation (DHR)vs ›

$137.13B

5.63

5.20

6.66

6.73

Bristol-Myers Squibb Company (BMY)vs ›

$133.37B

4.54

-0.48

1.47

0.84

CVS Health Corp. (CVS)vs ›

$133.25B

2.27

2.53

3.71

4.39

AstraZeneca PLC (AZN)vs ›

$131.47B

13.28

11.14

8.54

6.53

Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for Amgen Inc. (AMGN)?

The earnings per share (EPS) for AMGN stock is 14.37.

Is Amgen Inc.'s earnings per share (EPS) high or low?

The earnings per share (EPS) of 14.37 is 24% above its 5-year average of 11.57, near the high end of its 5-year range (7.62–14.37).

What is the TTM average earnings per share (EPS) for Amgen Inc. (AMGN)?

The TTM average earnings per share (EPS) for AMGN stock is 10.97.

What is the 3Y average earnings per share (EPS) for Amgen Inc. (AMGN)?

The 3Y average earnings per share (EPS) for AMGN stock is 11.67.

What is the 5Y average earnings per share (EPS) for Amgen Inc. (AMGN)?

The 5Y average earnings per share (EPS) for AMGN stock is 11.57.

What is the 10Y average earnings per share (EPS) for Amgen Inc. (AMGN)?

The 10Y average earnings per share (EPS) for AMGN stock is 10.66.

What is the 15Y average earnings per share (EPS) for Amgen Inc. (AMGN)?

The 15Y average earnings per share (EPS) for AMGN stock is 9.08.

What is the 20Y average earnings per share (EPS) for Amgen Inc. (AMGN)?

The 20Y average earnings per share (EPS) for AMGN stock is 7.71.

DATE	EARNINGS PER SHARE (EPS)
2025-12-31	14.33
2024-12-31	7.62
2023-12-31	12.56
2022-12-31	12.18
2021-12-31	10.34
2020-12-31	12.40
2019-12-31	12.96
2018-12-31	12.70
2017-12-31	2.71
2016-12-31	10.32
2015-12-31	9.15
2014-12-31	6.80
2013-12-31	6.75
2012-12-31	5.61
2011-12-31	4.07
2010-12-31	4.82
2009-12-31	4.53
2008-12-31	3.79
2007-12-31	2.83
2006-12-31	2.51
2005-12-31	2.97
2004-12-31	1.86
2003-12-31	1.75
2002-12-31	-1.21
2001-12-31	1.07
2000-12-31	1.11
1999-12-31	1.07
1998-12-31	0.85
1997-12-31	0.61
1996-12-31	0.61

DATE

EARNINGS PER SHARE (EPS)

2025-12-31

14.33

2024-12-31

7.62

2023-12-31

12.56

2022-12-31

12.18

2021-12-31

10.34

2020-12-31

12.40

2019-12-31

12.96

2018-12-31

12.70

2017-12-31

2.71

2016-12-31

10.32

2015-12-31

9.15

2014-12-31

6.80

2013-12-31

6.75

2012-12-31

5.61

2011-12-31

4.07

2010-12-31

4.82

2009-12-31

4.53

2008-12-31

3.79

2007-12-31

2.83

2006-12-31

2.51

2005-12-31

2.97

2004-12-31

1.86

2003-12-31

1.75

2002-12-31

-1.21

2001-12-31

1.07

2000-12-31

1.11

1999-12-31

1.07

1998-12-31

0.85

1997-12-31

0.61

1996-12-31

0.61

Earnings Per Share (EPS): 14.37

AMGN Earnings Per Share (EPS)

AMGN Quarterly EPS Growth (YoY)

AMGN Average Earnings Per Share (EPS) Chart

AMGN Current vs Average Earnings Per Share (EPS) Chart

AMGN Earnings Per Share (EPS) Metrics

AMGN Competitors' Earnings Per Share (EPS)

EPS Comparison

Earnings Per Share (EPS) Formula & Definition

Earnings Per Share (EPS) FAQ

AMGN Earnings Per Share (EPS) History

Related Metrics